1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Latin America Liver Cancer Market - Segmented by type, technology, end-user, and geography (2015 -2020)

Mordor Intelligence analysts forecasted the Latin America Liver Cancer Market to grow at a CAGR of 5-11% over the period, 2015-2020. The market is currently valued at USD 35 million for the year 2015.

Liver cancer represents the fifth most commonly occurring cancer and the third leading reason for cancer related deaths in the world. Nearly 800,000 people are annually diagnosed with primary carcinoma. Therefore, the liver cancer medication market is anticipated to become an active ground for competition in the future. Nexavar (sorafenib) is the dominant therapeutic in the market, and is additionally the most important targeted medical aid that is regularly used for advanced-stage carcinoma patients.

With only a few approved drugs within the market and another few in the pipeline, it is a proven fact that incidence and mortality from the sickness continues to rise worldwide. Many new-targeted therapies are expected to enter the market in the following few years. Targeted cancer therapies use medication to prevent the expansion of cancer cells by interrupting certain molecules, known as molecular targets, thereby preventing the progression and growth of cancer cells. The treatment, also known as 'molecular targeted therapy', focuses on the cellular and molecular changes, pertaining specifically to cancer. It is thereby more effective, as compared to the other treatments for cancer, including radiotherapy and chemotherapy.

The Latin America liver cancer market is segmented based on:
- Type
- Primary
- Secondary
- Benign liver growths
- Diagnosis
- Ultrasound scans
- Confirmatory needle biopsy
- Endoscopic ultrasound
- Laparoscopy
- CT scan
- PET scan
- Magnetic resonance imaging (MRI) scans
- Therapeutics
- Hepatocellular carcinoma
- Cholangiocarcinoma
- Hepatoblastoma
- Targeted therapy
- Others
- End-User
- Pediatrics
- Adults
- Geography
- Argentina
- Brazil.

Some of the key participants in the industry include Bayer Schering Pharma AG, Onyx Pharmaceuticals, Inc., Celsion Corp., Alnylam Pharmaceuticals, Inc., ArQule, Inc., 4SC AG, ImClone Systems Inc., Jennerex Biotherapeutics, Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., and Bristol-Myers Squibb Company. Etc.


Drivers:
- Increasing incidences of cancer
- Drug innovations with regard to the cancer
- Government initiatives
- Rise in aging populace
- Excessive alcohol consumptions
- High unmet needs for the treatment of liver cancer in the market
- Increasing health care expenditure


Restraints:
- Low success rate in clinical trials for cancer drugs
- Huge capital investments
- Low accessibility in remote areas
- Stringent regulatory procedures

Table Of Contents

Latin America Liver Cancer Market - Segmented by type, technology, end-user, and geography (2015 -2020)
1. Executive Summary
2. Research Methodology
3. Introduction
3.1 Report Description
3.2 Markets Covered
4. Market Overview
4.1 Market Definition
4.2 Market Drivers
4.2.1 aging population
4.2.2 Rising Government and Non-Government Funding for Vaccine Development
4.2.3 high unmet needs for the treatment of liver cancer
4.2.4 excessive alcohol consumptions
4.3 Market Restraints
4.3.1 Techinical Advancements
4.3.2 Huge Capital Investments
4.3.3 Stringent Regulatory Procedures
4.3.4 Low success rate in clinical trails for cancer drugs
4.4 Market Opportunitites
4.5 Market Threats
5. Porters Five Force Analysis
5.1 Bargaining Power of suppliers
5.2 Bargaining power of buyers
5.3 Degree of competition
5.4 Threat of substitution
5.5 Threat of new entrants
6. Market Segmentation
6.1 By Type
6.1.1 primary liver cancer
6.1.1.1 Hepatocellular carcinoma (HCC)
6.1.1.2 Angiosarcoma
6.1.1.3 Cholangiocarcinoma (bile duct cancer)
6.1.1.4 Hepatoblastoma
6.1.2 secondary liver cancer
6.1.3 Benign liver growths
6.2 Diagnosis
6.2.1 ultrasound scans
6.2.2 Confirmatory Needle biopsy
6.2.3 Endoscopic Ultrasound
6.2.4 Laparoscopy
6.2.5 CT Scan
6.2.6 PET Scan
6.2.7 magnetic resonance imaging (MRI) scans
6.3 Therapeutics
6.3.1 Hepatocellular carcinoma
6.3.2 Cholangiocarcinoma
6.3.3 Hepatoblastoma
6.3.4 Targeted therapy
6.3.5 Others
6.4 By End User
6.4.1 Pediatrics
6.4.2 Adults
6.5 By Geography
6.5.1 Argentina
6.5.2 Brazil
7. Competitive Landscape
7.1 Mergers and Acquisitions
7.2 Agreements, Collaborations and Partnerships
7.3 New Product Launches
7.4 Recommendations to new market players
7.5 Value Chain Analysis
8. Company Profiles
8.1 Bayer Schering Pharma AG,
8.2 Onyx Pharmaceuticals, Inc., Celsion Corp.,
8.3 Alnylam Pharmaceuticals, Inc.,
8.4 ArQule, Inc.,
8.5 4SC AG,
8.6 ImClone Systems Inc.,
8.7 Jennerex Biotherapeutics, Inc.,
8.8 Pfizer Inc.,
8.9 F Hoffmann-La Roche Ltd..,
8.10 Bristol-Myers Squibb Company.
9. Appendix
9.1 Abbrevations
9.2 Sources
9.3 Bibliography
9.4 Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Europe Cancer Diagnostic Testing Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology

2016 Europe Cancer Diagnostic Testing Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology

  • $ 34500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 925 pages and 366 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Oncology Market in the US

  • February 2017
    18 pages
  • Prescription Dr...  

  • United States  

View report >

Therapy Market in Sweden

  • February 2017
    8 pages
  • Therapy  

    Hormone  

    Antidiabetics  

  • Sweden  

View report >

Insulin Market and Diabetes Statistics in the US

  • February 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Related Market Segments :

Cancer

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.